Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies

Chung Pin Li, Tze Sing Huang, Yee Chao, Full Young Chang, Jacquline Whang-Peng, Shou Dong Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Aim: To evaluate the diagnostic value of assaying telomerase activity in ascites cells for the differential diagnosis of malignant and non-malignant ascites. Methods: Ascites from 40 patients with hepatocellular carcinoma (HCC), 31 with non-HCC gastrointestinal carcinoma (CA), and 24 with liver cirrhosis (LC) were analyzed for telomerase activity. The telomerase activities in cell pellets from ascites were measured according to the Telomeric Repeat Amplification Protocol (TRAP) and quantified with a densitometer. Results: Positive telomerase activity was detected in 16 of 31 (52%) CA patients, 10 of 40 (25%) HCC patients, and 1 of 24 (4%) LC patients (P<0.001). The telomerase activity was higher in the ascites of CA patients than in the ascites of HCC or LC patients (CA: 22.9±5.8, HCC: 6.7±2.5, LC: 1.3±1.3, P = 0.001). Cytology was positive in 18 CA patients (58%) and 1 HCC patient (2.5%), respectively. The positive telomerase activity was not related to patients' age, gender, and ascitic protein concentration, but to white blood count (r = 0.31, P = 0.002), neutrophil count (r = 0.29, P = 0.005), and the C-reactive protein level (r = 0.29, P = 0.018). When the results of both cytological examination and telomerase assay were considered together, the sensitivity increased to 77% for CA patients, 25% for HCC patients, and 48% for all 71 gastrointestinal cancer patients. Conclusion: Combining cytological examination of ascites with telomerase activity assay significantly improves the differential diagnosis between malignant and non-malignant ascites.

Original languageEnglish
Pages (from-to)2468-2471
Number of pages4
JournalWorld Journal of Gastroenterology
Volume10
Issue number17
Publication statusPublished - Sep 1 2004
Externally publishedYes

Fingerprint

Telomerase
Ascites
Gastrointestinal Tract
Hepatocellular Carcinoma
Neoplasms
Carcinoma
Liver Cirrhosis
Differential Diagnosis
Gastrointestinal Neoplasms
C-Reactive Protein
Cell Biology
Neutrophils

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies. / Li, Chung Pin; Huang, Tze Sing; Chao, Yee; Chang, Full Young; Whang-Peng, Jacquline; Lee, Shou Dong.

In: World Journal of Gastroenterology, Vol. 10, No. 17, 01.09.2004, p. 2468-2471.

Research output: Contribution to journalArticle

Li, Chung Pin ; Huang, Tze Sing ; Chao, Yee ; Chang, Full Young ; Whang-Peng, Jacquline ; Lee, Shou Dong. / Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies. In: World Journal of Gastroenterology. 2004 ; Vol. 10, No. 17. pp. 2468-2471.
@article{64a0788153884de69995414bffb0f83b,
title = "Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies",
abstract = "Aim: To evaluate the diagnostic value of assaying telomerase activity in ascites cells for the differential diagnosis of malignant and non-malignant ascites. Methods: Ascites from 40 patients with hepatocellular carcinoma (HCC), 31 with non-HCC gastrointestinal carcinoma (CA), and 24 with liver cirrhosis (LC) were analyzed for telomerase activity. The telomerase activities in cell pellets from ascites were measured according to the Telomeric Repeat Amplification Protocol (TRAP) and quantified with a densitometer. Results: Positive telomerase activity was detected in 16 of 31 (52{\%}) CA patients, 10 of 40 (25{\%}) HCC patients, and 1 of 24 (4{\%}) LC patients (P<0.001). The telomerase activity was higher in the ascites of CA patients than in the ascites of HCC or LC patients (CA: 22.9±5.8, HCC: 6.7±2.5, LC: 1.3±1.3, P = 0.001). Cytology was positive in 18 CA patients (58{\%}) and 1 HCC patient (2.5{\%}), respectively. The positive telomerase activity was not related to patients' age, gender, and ascitic protein concentration, but to white blood count (r = 0.31, P = 0.002), neutrophil count (r = 0.29, P = 0.005), and the C-reactive protein level (r = 0.29, P = 0.018). When the results of both cytological examination and telomerase assay were considered together, the sensitivity increased to 77{\%} for CA patients, 25{\%} for HCC patients, and 48{\%} for all 71 gastrointestinal cancer patients. Conclusion: Combining cytological examination of ascites with telomerase activity assay significantly improves the differential diagnosis between malignant and non-malignant ascites.",
author = "Li, {Chung Pin} and Huang, {Tze Sing} and Yee Chao and Chang, {Full Young} and Jacquline Whang-Peng and Lee, {Shou Dong}",
year = "2004",
month = "9",
day = "1",
language = "English",
volume = "10",
pages = "2468--2471",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "17",

}

TY - JOUR

T1 - Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies

AU - Li, Chung Pin

AU - Huang, Tze Sing

AU - Chao, Yee

AU - Chang, Full Young

AU - Whang-Peng, Jacquline

AU - Lee, Shou Dong

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Aim: To evaluate the diagnostic value of assaying telomerase activity in ascites cells for the differential diagnosis of malignant and non-malignant ascites. Methods: Ascites from 40 patients with hepatocellular carcinoma (HCC), 31 with non-HCC gastrointestinal carcinoma (CA), and 24 with liver cirrhosis (LC) were analyzed for telomerase activity. The telomerase activities in cell pellets from ascites were measured according to the Telomeric Repeat Amplification Protocol (TRAP) and quantified with a densitometer. Results: Positive telomerase activity was detected in 16 of 31 (52%) CA patients, 10 of 40 (25%) HCC patients, and 1 of 24 (4%) LC patients (P<0.001). The telomerase activity was higher in the ascites of CA patients than in the ascites of HCC or LC patients (CA: 22.9±5.8, HCC: 6.7±2.5, LC: 1.3±1.3, P = 0.001). Cytology was positive in 18 CA patients (58%) and 1 HCC patient (2.5%), respectively. The positive telomerase activity was not related to patients' age, gender, and ascitic protein concentration, but to white blood count (r = 0.31, P = 0.002), neutrophil count (r = 0.29, P = 0.005), and the C-reactive protein level (r = 0.29, P = 0.018). When the results of both cytological examination and telomerase assay were considered together, the sensitivity increased to 77% for CA patients, 25% for HCC patients, and 48% for all 71 gastrointestinal cancer patients. Conclusion: Combining cytological examination of ascites with telomerase activity assay significantly improves the differential diagnosis between malignant and non-malignant ascites.

AB - Aim: To evaluate the diagnostic value of assaying telomerase activity in ascites cells for the differential diagnosis of malignant and non-malignant ascites. Methods: Ascites from 40 patients with hepatocellular carcinoma (HCC), 31 with non-HCC gastrointestinal carcinoma (CA), and 24 with liver cirrhosis (LC) were analyzed for telomerase activity. The telomerase activities in cell pellets from ascites were measured according to the Telomeric Repeat Amplification Protocol (TRAP) and quantified with a densitometer. Results: Positive telomerase activity was detected in 16 of 31 (52%) CA patients, 10 of 40 (25%) HCC patients, and 1 of 24 (4%) LC patients (P<0.001). The telomerase activity was higher in the ascites of CA patients than in the ascites of HCC or LC patients (CA: 22.9±5.8, HCC: 6.7±2.5, LC: 1.3±1.3, P = 0.001). Cytology was positive in 18 CA patients (58%) and 1 HCC patient (2.5%), respectively. The positive telomerase activity was not related to patients' age, gender, and ascitic protein concentration, but to white blood count (r = 0.31, P = 0.002), neutrophil count (r = 0.29, P = 0.005), and the C-reactive protein level (r = 0.29, P = 0.018). When the results of both cytological examination and telomerase assay were considered together, the sensitivity increased to 77% for CA patients, 25% for HCC patients, and 48% for all 71 gastrointestinal cancer patients. Conclusion: Combining cytological examination of ascites with telomerase activity assay significantly improves the differential diagnosis between malignant and non-malignant ascites.

UR - http://www.scopus.com/inward/record.url?scp=4444251434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444251434&partnerID=8YFLogxK

M3 - Article

C2 - 15300886

AN - SCOPUS:4444251434

VL - 10

SP - 2468

EP - 2471

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 17

ER -